FI860711A7 - Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. - Google Patents

Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. Download PDF

Info

Publication number
FI860711A7
FI860711A7 FI860711A FI860711A FI860711A7 FI 860711 A7 FI860711 A7 FI 860711A7 FI 860711 A FI860711 A FI 860711A FI 860711 A FI860711 A FI 860711A FI 860711 A7 FI860711 A7 FI 860711A7
Authority
FI
Finland
Prior art keywords
dessa
innehaolllande
dikarboxylsyror
laekemedel
alfa
Prior art date
Application number
FI860711A
Other languages
English (en)
Finnish (fi)
Other versions
FI860711A0 (fi
Inventor
Jacob Bar-Tana
Ernst-Christian Witte
Bernd Hagenbruch
Johannes Pill
Karlheinz Stegmeier
Original Assignee
Epis Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epis Sa filed Critical Epis Sa
Publication of FI860711A0 publication Critical patent/FI860711A0/fi
Publication of FI860711A7 publication Critical patent/FI860711A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/26—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings
    • C07C55/28—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/32—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/34—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings containing more than one carboxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI860711A 1984-06-22 1986-02-17 Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar. FI860711A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843423166 DE3423166A1 (de) 1984-06-22 1984-06-22 Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
PCT/EP1985/000288 WO1986000298A1 (fr) 1984-06-22 1985-06-15 Acides alpha, omega dicarboxyliques, procede pour leur preparation et medicaments les renfermant

Publications (2)

Publication Number Publication Date
FI860711A0 FI860711A0 (fi) 1986-02-17
FI860711A7 true FI860711A7 (fi) 1986-02-17

Family

ID=6238954

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860711A FI860711A7 (fi) 1984-06-22 1986-02-17 Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar.

Country Status (17)

Country Link
US (1) US4711896A (OSRAM)
EP (1) EP0185080B1 (OSRAM)
JP (1) JPH0780807B2 (OSRAM)
AU (1) AU4607185A (OSRAM)
CA (1) CA1262552A (OSRAM)
DD (1) DD240541A5 (OSRAM)
DE (2) DE3423166A1 (OSRAM)
DK (1) DK75986A (OSRAM)
ES (1) ES8604090A1 (OSRAM)
FI (1) FI860711A7 (OSRAM)
GR (1) GR851509B (OSRAM)
HU (1) HUT38892A (OSRAM)
IL (1) IL75549A (OSRAM)
NO (1) NO860661L (OSRAM)
PT (1) PT80681B (OSRAM)
WO (1) WO1986000298A1 (OSRAM)
ZA (1) ZA854684B (OSRAM)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876279A (en) * 1986-05-05 1989-10-24 Merck & Co., Inc. Antihypercholesterolemic compounds
IL101708A (en) * 1992-04-28 1996-08-04 Senyorina Ltd Anti-fattening drugs comprising amino acid derivatives
US5602164A (en) * 1992-04-28 1997-02-11 Senyorina Ltd. Anti-obesity drugs
TW322493B (OSRAM) * 1994-06-27 1997-12-11 Shell Int Research
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
IL119971A (en) * 1997-01-07 2003-02-12 Yissum Res Dev Co Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
IL121165A0 (en) 1997-06-26 1997-11-20 Yissum Res Dev Co Pharmaceutical compositions containing carboxylic acids and derivatives thereof
US20020037876A1 (en) * 1998-06-25 2002-03-28 Yissum Research Development Company Of Hebrew University Of Jerusalem Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
DE60037818D1 (de) 1999-04-01 2008-03-06 Esperion Therapeutics Inc Ether-verbindungen, zusammensetzungen und ihre verwendung
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
IL155247A0 (en) 2000-10-11 2003-11-23 Esperion Therapeutics Inc Sulfide and disulfide compounds and compositions for cholesterol management and related uses
MXPA03003024A (es) 2000-10-11 2003-07-14 Esperion Therapeutics Inc Compuestos de sulfoxido y bis-sulfoxido y composiciones para el control de colesterol y usos relacionados.
US6713507B2 (en) 2000-10-11 2004-03-30 Esperion Therapeutics, Inc. Ether compounds and compositions for cholesterol management and related uses
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
BRPI0114622B8 (pt) 2000-10-11 2021-05-25 Esperion Therapeutics Inc composto, composição farmacêutica compreendendo o mesmo e uso do referido composto na preparação de composição farmacêutica
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
CA2480410A1 (en) * 2002-04-10 2003-10-23 Esperion Therapeutics, Inc. Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
BR0312426A (pt) * 2002-07-03 2005-12-06 Esperion Therapeutics Inc Composição farmacêutica, métodos para tratar, prevenir ou controlar um colesterol, dislipidemia ou distúrbio relacionado, para reduzir ou evitar um efeito adverso associado com monoterapia de pantetina e para reduzir ou evitar um efeito adverso associado com monoterapia de segundo agente ativo, e, kit
US20040048910A1 (en) * 2002-08-22 2004-03-11 Bove Susan Elizabeth Method of treating osteoarthritis
EP2402300B1 (en) * 2003-01-23 2016-05-25 Esperion Therapeutics Inc. Hydroxyl compounds and compositions for cholesterol management and related uses
WO2005002557A1 (en) * 2003-07-03 2005-01-13 Warner-Lambert Company Llc Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
JP4839221B2 (ja) * 2003-11-07 2011-12-21 ジェイ ジェイ ファーマ，インコーポレイテッド Ｈｄｌを高める併用療法用複合物
US20050192347A1 (en) * 2003-12-23 2005-09-01 Dasseux Jean-Louis H. Urea and thiourea compounds and compositions for cholesterol management and related uses
JP2007525408A (ja) 2003-12-24 2007-09-06 エスペリオン セラピューティクス，インコーポレイテッド コレステロール管理および関連使用のためのケトン化合物および組成物
EP1699448A4 (en) * 2003-12-30 2010-11-03 Syndromex Ltd PROCESS FOR THE ADMINISTRATION OF 3,3,14,14-TETRAMETHYL-HEXADECANE-1,16-DIONIC ACID
CN1964955A (zh) * 2004-06-09 2007-05-16 阿文尼尔药品公司 治疗高胆固醇血症及相关疾病的小分子
JP2008502736A (ja) * 2004-06-09 2008-01-31 アバニール・ファーマシューティカルズ 高脂血症および関連疾患の治療のための複素環式誘導体
AR049081A1 (es) * 2004-06-09 2006-06-21 Avanir Pharmaceuticals Mediadores del transporte inverso de colesterol para el tratamiento de la hipercolesterolemia
EP1838296B1 (en) * 2004-10-20 2012-08-08 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
US8410109B2 (en) * 2005-07-29 2013-04-02 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
AU2007345526B2 (en) * 2007-02-01 2013-02-28 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular diseases
IL181577A0 (en) * 2007-02-26 2007-07-04 Jacob Bar Tana Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders
DK2167069T3 (da) 2007-05-23 2011-11-21 Amcol International Corp Cholesterol-interagerende lagdelte phyllosilikater og fremgangsmåder til at reducere hypercholesterolæmi hos et pattedyr
HRP20150477T8 (hr) 2008-06-26 2016-10-21 Resverlogix Corp. Postupci dobivanja derivata kinazolona
AU2010204106B2 (en) 2009-01-08 2014-05-08 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
MX392179B (es) 2009-03-18 2025-03-21 Resverlogix Corp Nuevos agentes anti-inflamatorios.
TR201818390T4 (tr) 2009-04-22 2019-01-21 Resverlogix Corp Yeni̇ anti̇-i̇nflamatuvar ajanlar
MX2012002639A (es) 2009-09-03 2012-03-14 Pfizer Vaccines Llc Vacuna de pcsk9.
JP2013537240A (ja) 2010-09-20 2013-09-30 カリウス セラピューティクス エスエー 糖尿病および脂質異常症の処置のための方法および組成物
WO2012131504A1 (en) 2011-03-02 2012-10-04 Pfizer Inc. Pcsk9 vaccine
ES2745471T3 (es) 2011-11-01 2020-03-02 Resverlogix Corp Formulaciones orales de liberación inmediata para quinazolinonas sustituidas
US10479752B2 (en) 2011-12-08 2019-11-19 Syndromex Ltd. Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
EP2935253B1 (en) 2012-12-21 2018-08-01 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
EP3104877B1 (en) 2014-02-11 2020-01-22 The USA, as represented by The Secretary, Department of Health and Human Services Pcsk9 vaccine and methods of using the same
KR102662814B1 (ko) 2015-03-13 2024-05-03 리스버로직스 코퍼레이션 보체 관련 질환을 치료하기 위한 조성물 및 치료 방법
US10912751B2 (en) 2015-03-13 2021-02-09 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
CN107118098B (zh) * 2016-02-25 2020-07-14 中国科学院上海药物研究所 一类脂肪酸类化合物、其制备方法及其用途
US10512624B2 (en) 2016-11-30 2019-12-24 Syndromex Ltd. Long-chain amphipathic dicarboxylic acids for treatment of diabetes type-1
JP2022537049A (ja) 2019-06-21 2022-08-23 エスペリオン・セラピューティクス・インコーポレイテッド ベンペド酸の製造方法及びその組成物
IL289919B2 (en) 2019-07-26 2025-10-01 Espervita Therapeutics Inc Long-chain functional mono- and dicarboxylic acids, useful for the prevention or treatment of diseases
US11730712B2 (en) 2021-01-25 2023-08-22 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
MX2023008567A (es) 2021-01-25 2023-08-28 Espervita Therapeutics Inc Acidos monocarboxilicos y dicarboxilicos de hidrocarburos de cadena larga funcionalizados y derivados de estos, y su uso para la prevencion o el tratamiento de enfermedades.
CN115894220A (zh) * 2021-09-23 2023-04-04 中国科学院上海药物研究所 一类作用于acly的长链类化合物、其制备方法及其用途
CN115887435A (zh) * 2021-09-23 2023-04-04 博骥源（上海）生物医药有限公司 长链类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210786B (de) * 1962-12-17 1966-02-17 Shell Int Research Verfahren zur Herstellung von p-Phenylen-bis (3, 3'-isovaleriansaeure) und 3-Phenylisovalerian-saeure
GB1556660A (en) * 1975-10-07 1979-11-28 Akzo Nv Di-carboxylic acid derivatives
IL64542A0 (en) * 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0185080B1 (de) 1989-11-08
PT80681B (de) 1987-05-08
DE3574130D1 (en) 1989-12-14
ZA854684B (en) 1986-02-26
ES544439A0 (es) 1986-02-01
PT80681A (de) 1985-07-01
JPS61502537A (ja) 1986-11-06
FI860711A0 (fi) 1986-02-17
IL75549A (en) 1989-03-31
DK75986D0 (da) 1986-02-18
HUT38892A (en) 1986-07-28
EP0185080A1 (OSRAM) 1986-06-25
GR851509B (OSRAM) 1985-06-25
AU4607185A (en) 1986-01-24
DE3423166A1 (de) 1986-01-02
DD240541A5 (de) 1986-11-05
ES8604090A1 (es) 1986-02-01
WO1986000298A1 (fr) 1986-01-16
NO860661L (no) 1986-02-21
CA1262552A (en) 1989-10-31
IL75549A0 (en) 1985-10-31
US4711896A (en) 1987-12-08
JPH0780807B2 (ja) 1995-08-30
DK75986A (da) 1986-02-18

Similar Documents

Publication Publication Date Title
FI863200A7 (fi) Kolfibriller, foerfarande foer framstaellning av desamma samt kompositioner innehaollande desamma.
FI860711A7 (fi) Alfa-, omega-dikarboxylsyror, foerfarande foer framstaellning av dessa samt laekemedel innehaolllande dessa foereningar.
FI852203A0 (fi) 7-amino-1-cyklopropyl-6, 8-dihalogen-1, 4-dihydro-4-oxo-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning samt dessa innehaollande antibakteriella aemnen.
FI853611A0 (fi) Bloedningshaemmande proteiner, foerfarande foer framstaellning samt deras anvaendning.
FI842110L (fi) Foerfarande foer styrning av saogblad, samt anordning foer utfoerande av foerfarandet.
FI855053L (fi) Foerfarande foer aostadkommande av en roerelsesignal samt mri-tomografianlaeggning foer utfoerande av naemnda foerfarande.
FI862893A0 (fi) Foerfarande foer mottagning av radiosaenda meddelanden samt mottagare foer aendamaolet.
FI852965L (fi) Avskrapningsanordning samt foerfarande, daer det anvaendes foerspaennt avskrapningsbett.
FI854466A0 (fi) Alkyl-1-cyklopropyl-1,4-dihydro-4 -oxo-3-kinolinkarboxylsyror, foerfaranden foer framstaellning av dessa samt dessa innehaollande antibakteriella medel.
FI851736A0 (fi) Amidinohydrazoner av tetralin-, kromon-, tiokromon- och tetrahydrokinolinderivat, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel.
FI880164A0 (fi) Staolband samt av staolbandet framstaellt verktyg.
FI861257A7 (fi) Antistatiska hoegre n-alkyl- och n-alkenylneoalkanoamider, foerfarande foer framstaellning av dessa, antistatiska kompositioner innehaollande saodana amider samt foerfarande foer minskning av ackumulering av statiska laddningar i tvaett.
FI860426L (fi) Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex.
FI843959A0 (fi) Nytt foerfarande foer framstaellning av kefalosporiner, vid framstaellning av kefalosporin anvaendbar mellanprodukt samt foerfarande foer framstaellning av naemnda mellanprodukt.
FI863837L (fi) Foerfarande foer foerpackning av livsmedel, saerskilt matportioner samt medelst foerfarandet aostadkommen foerpackning.
FI841003L (fi) Foerfarande foer framstaellning av staellningar, speciellt stegar.
FI855085A7 (fi) En blandning av olika dihydropyridiner, foerfarande foer deras framstaellning samt deras anvaendning i laekemedel.
FI861073A0 (fi) Foerfarande foer framstaellning av guanidiner, saosom linoglirid, samt foerfarande foer framstaellning av mellanprodukter.
FI852914L (fi) Fjaederkraftackumulator foer en av lasten beroende samt fjaerrstyrd frigoering av en dornfoersedd lastmottagande anordning.
FI853882A0 (fi) Foerfarande foer framstaellning av cellulosafiber respektive aendloesa cellulosafiber samt anordning foer utfoerande av foerfarandet.
FI841632A7 (fi) Foerfarande foer framstaellning av laett instaellbara, haollbara anod- och jaernfoerelseelektrodkomponenter foer katodiskt skydd.
FI840835A7 (fi) Foerfarande foer tillverkning av en ihaolig traestaong, anordning foer tillaempning av foerfarandet samt en med foerfarandet aostadkommen ihaolig traestaong.
FI852934A0 (fi) Foerfarande foer montering av lagerlamellen i kamrullen i en hydraulmotors kolv, lageranordning foer kamrulle samt en lagerlamell.
FI840067A7 (fi) Foerfarande foer vaermeisolering av vaeggkonstruktion samt vaermeisolerad vaegg.
FI893256A0 (fi) 1-aminoalkylsubstituerade indolderivat samt framstaellning av dessa.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: EPIS S.A.